Rocket Pharmaceuticals (RCKT) Short Interest
Nasdaq • RCKT • US77313F1066
As of Oct 27, 2026, ORTEX estimated 18.5% of free float sold short, 7.3 days to cover, cost to borrow 0.42%. Sign up for live short interest data.
Nasdaq • RCKT • US77313F1066
As of Oct 27, 2026, ORTEX estimated 18.5% of free float sold short, 7.3 days to cover, cost to borrow 0.42%. Sign up for live short interest data.
This page tracks how heavily Rocket Pharmaceuticals (Nasdaq:RCKT) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Rocket Pharmaceuticals (Nasdaq: RCKT) has a market capitalization of $272.24M. Last close $2.48 (as of 2026-11-12); 52-week range $2.17 to $5.45. ORTEX data as of 2026-10-27: short interest was 18.54% of free float, 7.3 days to cover and the average cost to borrow was 0.42%. Sign up for live short interest data.